A prevalence study in Guadalajara, Mexico, comparing tuberculin skin test and QuantiFERON-TB Gold In-Tube
- PMID: 35271625
- PMCID: PMC8912134
- DOI: 10.1371/journal.pone.0264982
A prevalence study in Guadalajara, Mexico, comparing tuberculin skin test and QuantiFERON-TB Gold In-Tube
Abstract
Background: Tuberculosis (TB) is a prevalent disease throughout the world. The extent of TB illness in childhood is not clear; recent data shows that 10-20% of the cases are found in children under 15 years old. In 2017, 1 million children developed the disease, of which 9% were co-infected with HIV.
Methods: A cross-sectional study that analyzed 48 children diagnosed with HIV-infection in Guadalajara, Mexico. The tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube test (QFT) were performed and compared to diagnose latent TB infection (LTBI).
Results: The average age was 9 years old (± 4), with an age range of 1-16 years; the 6-12-year-old group predominated with 50% of cases. 27 patients (56%) were male; 83% had received the BCG vaccination and 23% had a history of being contacts of TB cases. In the study, 40 patients (83%) were without immunosuppression; seven (15%) with moderate immunosuppression, and only one patient had severe immunodeficiency. Overall, 3 of the 48 children (6.2%) had a positive TST, while 8 out of 48 (16.6%) had a positive QFT. The concordance between the two tests was 89.6% (43/48) with Kappa = 0.5 (95% CI, 0.14-0.85).
Conclusions: The QFT test represents an opportunity in the diagnosis of LTBI, particularly in pediatric HIV- patients. This is the first study that compares the two tests (TST and QFT) in children with HIV-infection in Guadalajara, Mexico.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.J Microbiol Immunol Infect. 2016 Oct;49(5):729-736. doi: 10.1016/j.jmii.2014.08.010. Epub 2014 Nov 1. J Microbiol Immunol Infect. 2016. PMID: 25442858
-
Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.J Trop Pediatr. 2021 Dec 8;67(6):fmab103. doi: 10.1093/tropej/fmab103. J Trop Pediatr. 2021. PMID: 34904674
-
QuantiFERON-TB Gold In-Tube test performance in a large pediatric population investigated for suspected tuberculosis infection.Paediatr Respir Rev. 2019 Nov;32:36-47. doi: 10.1016/j.prrv.2019.03.010. Epub 2019 Apr 22. Paediatr Respir Rev. 2019. PMID: 31155511
-
Tuberculosis in Infants and Children.Microbiol Spectr. 2017 Apr;5(2):10.1128/microbiolspec.tnmi7-0037-2016. doi: 10.1128/microbiolspec.TNMI7-0037-2016. Microbiol Spectr. 2017. PMID: 28387193 Free PMC article. Review.
-
Tuberculosis in childhood and adolescence: a view from different perspectives.J Pediatr (Rio J). 2020 Mar-Apr;96 Suppl 1(Suppl 1):99-110. doi: 10.1016/j.jped.2019.11.002. Epub 2019 Dec 18. J Pediatr (Rio J). 2020. PMID: 31862302 Free PMC article. Review.
References
-
- World Health Organization. Global tuberculosis report 2019. https://apps.who.int/iris/handle/10665/329368. Assessed 15 Jan 2020.
-
- Secretaría de Salud. Distribución de casos nuevos de enfermedad por grupos de edad. Estados Unidos Mexicanos 2019. Población General. México: SSA, 2020. Disponible en:https://epidemiologia.salud.gob.mx/anuario/2019/morbilidad/nacional/dist.... Assessed 11 Oct 2021.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical